North America Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 678 | Pages: 144 | October 2016 | Region: North America


The North America Vaccine Adjuvant Market was worth $160.48 million in 2016 and estimated to be growing at a CAGR of 10.3%, to reach $262 million by 2021. North America is dominating vaccine adjuvant market globally. Growth in the North American segment is mainly driven by the fast increasing elderly population and rising government funding in the North American countries.

Vaccine adjuvants benefit in the improvement of novel and advanced vaccine, which was not probable earlier due to less effectiveness of vaccine using only antigen. Adjuvants are progressively used in the advancement of harmless and effective vaccine as they create strong, long-lasting defensive immune response with a high edge of safety against infections. 

This market is largely driven by aspects such as increasing prevalence of diseases such as allergy, cancer, and HIV/AIDS; rising demand for innovative treatment options, and improvement of enhanced vaccine immunization. Upsurge in alliances and acquisitions by private organizations and augmented funding by government bodies for research and development are also expected to drive market growth. Major factor hindering the growth of the vaccine adjuvant market is stringent regulation for development of new vaccines.

The North America vaccine adjuvants market is segmented on the basis of type into Aluminium Salts, Tensoactive Adjuvants, Adjuvant emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants. Based on route of administration, the market is divided into oral, intradermal, subcutaneous, intranasal and intramuscular. The market is bifurcated on the basis of mechanism of action into active immuno stimulants, carriers and vehicle adjuvants. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. Based on geography the market is analysed under various regions namely, USA and Canada. North America region is led by USA due to increasing awareness regarding vaccines, followed by Canada.

The key players in the vaccine adjuvants market include MPV Technologies (U.S.), Avanti Polar Lipids, Novavax Inc. (U.S.), Inc. (U.S.), Brenntag Biosector (Denmark), SEPPIC (France), Agenus, Inc. (U.S.), Invivogen (U.S.), SPI Pharma, Inc. (U.S.), CSL Limited (Australia), and OZ Biosciences (France).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Vaccine Adjuvant Market By Region, From 2016-2021 (USD Million)
  2. North America Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  3. North America Aluminium Salts Market By Region, From 2016-2021 (USD Million)
  4. North America Tensoactive Adjuvants Market By Region, From 2016-2021 (USD Million)
  5. North America Adjuvant Emulsions Market By Region, From 2016-2021 (USD Million)
  6. North America Bacteria derived Adjuvants Market By Region, From 2016-2021 (USD Million)
  7. North America Liposome Adjuvants Market By Region, From 2016-2021 (USD Million)
  8. North America Carbohydrate Adjuvants Market By Region, From 2016-2021 (USD Million)
  9. North America Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  10. North America Oral Market By Region, From 2016-2021 (USD Million)
  11. North America Intradermal Market By Region, From 2016-2021 (USD Million)
  12. North America Subcutaneous Market By Region, From 2016-2021 (USD Million)
  13. North America Intranasal Market By Region, From 2016-2021 (USD Million)
  14. North America Intramuscular Market By Region, From 2016-2021 (USD Million)
  15. North America Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  16. North America Immuno Stimulants Market By Region, From 2016-2021 (USD Million)
  17. North America Carriers Market By Region, From 2016-2021 (USD Million)
  18. North America Vehicle Adjuvants Market By Region, From 2016-2021 (USD Million)
  19. United States Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  20. United States Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  21. United States Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  22. Canada Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  23. Canada Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  24. Canada Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
North America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Middle East And Africa High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application...
Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Europe High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glau...
Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology...
High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, H...
North America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Middle East And Africa Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pestici...
Latin America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Europe Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...
Asia Pacific Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screeni...
Global Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.